EUVIMEDEUVIMED entdecken
Crossref

Rhus chinensis Mill Derived Anti‐Allergic Ingredients Screening Using MAS‐Related G Protein‐Coupled Receptor X2 Cell Membrane Chromatography

Jinjin Wang, Na Guo, Quan Zhang, Runpeng Gu, Yanni Lv iD

Biomedical Chromatography · 2025

DOI: 10.1002/bmc.70203 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, 2025. Verfasst von Jinjin Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Health Science Center, Xi'an Jiaotong University, Xi'an, China. Hauptthemen laut MEDLINE: Receptors, G-Protein-Coupled, Anti-Allergic Agents, Rhus, Receptors, Neuropeptide. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Shaanxi Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mas‐related G‐protein coupled receptor member X2 (MrgprX2) serves as a potential therapeutic target for pseudoallergic reactions. Cell membrane chromatography (CMC) is an efficient and reliable technique for screening active components from complex systems, which can be used to search for MrgprX2 antagonists in herbs. Therefore, we used a previously constructed MrgprX2‐HALO‐tag/CMC‐HPLC‐MS system specifically for identifying natural antagonists. Rhus chinensis Mill has been found to possess anti‐inflammatory activities, but its active components targeting MrgprX2 remain unexplored. In this study, the MrgprX2‐HALO‐tag/CMC‐HPLC‐MS method successfully identified fisetin as the first reported MrgprX2‐targeting component from Rhus chinensis Mill. Through frontal analysis, we demonstrated that fisetin exhibits strong binding affinity ( K D = 2.02 μM) with MrgprX2, representing the first quantitative assessment of this interaction. Molecular docking revealed four key binding residues (TRP248, ASP184, LEU247, and GLU164) that form stable interactions with fisetin. Pharmacological validation using LAD2 cells confirmed fisetin's potent anti‐allergic activity via MrgprX2 antagonism. In summary, these findings not only identify fisetin as an active constituent of Rhus chinensis Mill but also further confirm that it targeted MrgprX2 to exert anti‐inflammatory properties, offering new perspectives for developing anti‐pseudoallergic therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, G-Protein-CoupledAnti-Allergic AgentsRhusReceptors, NeuropeptideNerve Tissue ProteinsPlant ExtractsMolecular Docking SimulationHumansChromatography, High Pressure LiquidFlavonoidsCell LineAnimalsMass SpectrometryCell Membrane

Stichwörter der Autor:innen

MrgprX2Rhus chinensis Millanaphylaxiscell membrane chromatographyfisetin

Substanzen

Receptors, G-Protein-CoupledAnti-Allergic AgentsFlavonoidsReceptors, NeuropeptideMRGPRX2 protein, humanNerve Tissue ProteinsPlant Extracts

Autor:innen und Institutionen

  • School of Pharmacy, Health Science Center, Xi'an Jiaotong University, Xi'an, China.
  • Institute of Pharmaceutical Science and Technology, Western China Science & Technology Innovation Harbour, Xi'an, China.

ORCID-Profile: Yanni Lv

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Shaanxi Province

Zitieren

APA

Wang, J., Guo, N., Zhang, Q., Gu, R., & Lv, Y. (2025). Rhus chinensis Mill Derived Anti‐Allergic Ingredients Screening Using MAS‐Related G Protein‐Coupled Receptor X2 Cell Membrane Chromatography. Biomedical Chromatography. https://doi.org/10.1002/bmc.70203

Vancouver

Wang J, Guo N, Zhang Q, Gu R, Lv Y. Rhus chinensis Mill Derived Anti‐Allergic Ingredients Screening Using MAS‐Related G Protein‐Coupled Receptor X2 Cell Membrane Chromatography. Biomedical Chromatography. 2025. doi:10.1002/bmc.70203

BibTeX
@article{Wang2025,
  author = {Wang, Jinjin and Guo, Na and Zhang, Quan and Gu, Runpeng and Lv, Yanni},
  title = {Rhus chinensis Mill Derived Anti‐Allergic Ingredients Screening Using MAS‐Related G Protein‐Coupled Receptor X2 Cell Membrane Chromatography},
  journal = {Biomedical Chromatography},
  year = {2025},
  doi = {10.1002/bmc.70203}
}
Kostenlos starten →